Articles Tagged With:
-
12 Months of Itraconazole Is Superior to Six Months for Preventing Relapses of Chronic Pulmonary Aspergillosis
A randomized, controlled clinical trial from India found a significant reduction in relapses of chronic pulmonary aspergillosis in patients treated with itraconazole for 12 months compared to those treated for six months. There were more adverse events in the patients treated for 12 months.
-
COVID-19 Rebound
Symptomatic and virologic recrudescence after treatment of patients with COVID-19 with nirmatrelvir/ritonavir (Paxlovid) — Paxlovid rebound — occurs in a very small percentage of patients and generally is mild and self-limited.
-
Paxlovid Rebound Concerns Are Overblown
A cohort of 483 high-risk patients was treated with nirmatrelvir/ritonavir for COVID-19. Two of the patients (0.4%) required hospitalization by day 30, and four patients (0.8%) experienced a rebound of symptoms (generally mild) at median of nine days after treatment. All resolved without additional COVID-19-directed therapy.
-
COVID-19: Duration of Shedding of Transmissible Virus
Patients with COVID-19 were found, by culture, to shed replication-competent virus after an initial positive polymerase chain reaction test for median durations four to five days.
-
Feds Ship Vaccine to States as Monkeypox Outbreak Expands
Public health officials are shipping monkeypox vaccines to states with ongoing transmission and to protect high-risk populations, such as men who have sex with men and those with human immunodeficiency virus.
-
Sterile Processing: Breakdowns in the Work … and the Workers
Improperly reprocessed medical instruments are associated with an increased risk of surgical site infection. A good understanding of your facility's sterile processing department can help ensure all areas touched by instrument reprocessing are working well together.
-
Under Cover of the Pandemic, a Deadly Fungus Spreads
While eclipsed by the COVID-19 pandemic, the multidrug-resistant fungus Candida auris continues to emerge in the healthcare settings and step-down facilities that can serve as reservoirs.
-
Clinician: Vaccinate Children to Prevent Long COVID
With public health officials recently recommending vaccinating children as young as 6 months of age for COVID-19, a clinician voiced a passionate plea to immunize this vulnerable population to prevent severe outcomes and death.
-
A Matter of Semantics: IP Requirements in LTC
The Association for Professionals in Infection Control and Epidemiology has been calling for infection preventionists in long-term care for years, but it took a pandemic and a catastrophic death toll among frail residents to finally spur substantive action from the government.
-
A Shot in the Dark: FDA Adding Omicron to New Fall Vaccine
With the Omicron BA.5 subvariant currently the dominant strain of COVID-19 in the United States, vaccine experts have decided to add some component of the rapidly mutating virus to a new bivalent booster that will be rolled out this fall.